在不列颠哥伦比亚省毒品非刑事化政策实施的第一年,吸毒者的污名化经历:一项定性研究

IF 4.4 2区 医学 Q1 SUBSTANCE ABUSE
Farihah Ali , Cayley Russell , Savannah Torres-Salbach , Margret Lo , Matthew Bonn , Geoff Bardwell , Juls Budau , Elaine Hyshka , Jürgen Rehm
{"title":"在不列颠哥伦比亚省毒品非刑事化政策实施的第一年,吸毒者的污名化经历:一项定性研究","authors":"Farihah Ali ,&nbsp;Cayley Russell ,&nbsp;Savannah Torres-Salbach ,&nbsp;Margret Lo ,&nbsp;Matthew Bonn ,&nbsp;Geoff Bardwell ,&nbsp;Juls Budau ,&nbsp;Elaine Hyshka ,&nbsp;Jürgen Rehm","doi":"10.1016/j.drugpo.2025.104791","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>On January 31, 2023, Health Canada approved a three-year pilot decriminalization initiative allowing adults in British Columbia (BC), Canada, to legally possess a cumulative 2.5 g of opioids, cocaine, methamphetamine, or MDMA. The policy aims to reduce the harms associated with drug use, including stigma, which contributes to barriers for people who use drugs in accessing harm reduction and treatment services. Addressing stigma is considered a crucial step in mitigating BC's overdose crisis, by encouraging people who use drugs to feel more comfortable to access and utilize services without fear of judgment. This study examined the impacts of the decriminalization policy on stigma among people who use drugs within the first year of implementation.</div></div><div><h3>Methods</h3><div>From October 2023 to February 2024, 100 semi-structured telephone interviews and brief socio-demographic surveys with people who use drugs from across BC were conducted to explore their experiences of stigmatization post-decriminalization. A qualitative thematic analysis was used to synthesize the data.</div></div><div><h3>Results</h3><div>Findings revealed that societal, structural and self-stigma remain pervasive among people who use drugs post-decriminalization. While most participants reported little change in their experiences of stigma since the policy's implementation, some reported an increase, while others observed a decrease across all forms of stigma. Increased stigma was attributed to perceived heightened visibility of public drug use, which amplified societal stigma. Conversely, decreased stigma was linked to shifting public perceptions of drug use as a public health issue and more humanized interactions with the police. Despite mixed experiences, participants remained optimistic that the policy could contribute to long-term stigma reduction and offered recommendations to support this goal.</div></div><div><h3>Conclusion</h3><div>While decriminalization has the potential to reduce stigma and increase comfort in accessing critical harm reduction and substance use treatment services among people who use drugs, achieving these outcomes requires additional efforts. Public awareness campaigns, targeted anti-stigma education, and broader systemic changes were suggested by participants as essential to address stigmatization in BC. Strengthening these areas could enhance access to and utilization of services, ultimately supporting the broader goals of decriminalization.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"139 ","pages":"Article 104791"},"PeriodicalIF":4.4000,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy: A qualitative study\",\"authors\":\"Farihah Ali ,&nbsp;Cayley Russell ,&nbsp;Savannah Torres-Salbach ,&nbsp;Margret Lo ,&nbsp;Matthew Bonn ,&nbsp;Geoff Bardwell ,&nbsp;Juls Budau ,&nbsp;Elaine Hyshka ,&nbsp;Jürgen Rehm\",\"doi\":\"10.1016/j.drugpo.2025.104791\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>On January 31, 2023, Health Canada approved a three-year pilot decriminalization initiative allowing adults in British Columbia (BC), Canada, to legally possess a cumulative 2.5 g of opioids, cocaine, methamphetamine, or MDMA. The policy aims to reduce the harms associated with drug use, including stigma, which contributes to barriers for people who use drugs in accessing harm reduction and treatment services. Addressing stigma is considered a crucial step in mitigating BC's overdose crisis, by encouraging people who use drugs to feel more comfortable to access and utilize services without fear of judgment. This study examined the impacts of the decriminalization policy on stigma among people who use drugs within the first year of implementation.</div></div><div><h3>Methods</h3><div>From October 2023 to February 2024, 100 semi-structured telephone interviews and brief socio-demographic surveys with people who use drugs from across BC were conducted to explore their experiences of stigmatization post-decriminalization. A qualitative thematic analysis was used to synthesize the data.</div></div><div><h3>Results</h3><div>Findings revealed that societal, structural and self-stigma remain pervasive among people who use drugs post-decriminalization. While most participants reported little change in their experiences of stigma since the policy's implementation, some reported an increase, while others observed a decrease across all forms of stigma. Increased stigma was attributed to perceived heightened visibility of public drug use, which amplified societal stigma. Conversely, decreased stigma was linked to shifting public perceptions of drug use as a public health issue and more humanized interactions with the police. Despite mixed experiences, participants remained optimistic that the policy could contribute to long-term stigma reduction and offered recommendations to support this goal.</div></div><div><h3>Conclusion</h3><div>While decriminalization has the potential to reduce stigma and increase comfort in accessing critical harm reduction and substance use treatment services among people who use drugs, achieving these outcomes requires additional efforts. Public awareness campaigns, targeted anti-stigma education, and broader systemic changes were suggested by participants as essential to address stigmatization in BC. Strengthening these areas could enhance access to and utilization of services, ultimately supporting the broader goals of decriminalization.</div></div>\",\"PeriodicalId\":48364,\"journal\":{\"name\":\"International Journal of Drug Policy\",\"volume\":\"139 \",\"pages\":\"Article 104791\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Drug Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955395925000908\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925000908","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

2023年1月31日,加拿大卫生部批准了一项为期三年的非刑事化试点计划,允许加拿大不列颠哥伦比亚省(BC)的成年人合法拥有累计2.5克阿片类药物、可卡因、甲基苯丙胺或摇头丸。该政策旨在减少与吸毒有关的危害,包括污名化,因为污名化会阻碍吸毒者获得减少危害和治疗服务。解决耻辱感问题被认为是减轻不列颠哥伦比亚省吸毒过量危机的关键一步,鼓励吸毒者更放心地获得和利用服务,而不必担心受到评判。本研究考察了非刑事化政策在实施的第一年对吸毒者的污名化的影响。方法从2023年10月至2024年2月,对不列颠哥伦比亚省各地的吸毒者进行了100次半结构化电话访谈和简短的社会人口调查,以了解他们在除罪化后的污名化经历。采用定性专题分析对数据进行综合分析。研究结果显示,社会、结构和自我耻辱感在非刑事化后的吸毒者中仍然普遍存在。虽然大多数参与者报告说,自政策实施以来,他们的耻辱经历几乎没有变化,但一些人报告说,耻辱有所增加,而另一些人则观察到所有形式的耻辱都有所减少。耻辱感的增加归因于公众对药物使用的高度关注,这放大了社会耻辱感。相反,耻辱感的减少与公众对吸毒作为一个公共卫生问题的看法的转变以及与警方更人性化的互动有关。尽管经验参差不齐,但与会者仍然乐观地认为,该政策可以有助于长期减少污名化,并提出了支持这一目标的建议。结论虽然非刑事化有可能减少吸毒者的耻辱感,增加他们在获得减少危害和药物使用治疗服务方面的舒适度,但要实现这些结果需要额外的努力。与会者建议,公众意识运动、有针对性的反污名化教育和更广泛的系统性变革是解决不列颠哥伦比亚省污名化问题的关键。加强这些领域可以增加获得和利用服务的机会,最终支持非刑事化的更广泛目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy: A qualitative study

Background

On January 31, 2023, Health Canada approved a three-year pilot decriminalization initiative allowing adults in British Columbia (BC), Canada, to legally possess a cumulative 2.5 g of opioids, cocaine, methamphetamine, or MDMA. The policy aims to reduce the harms associated with drug use, including stigma, which contributes to barriers for people who use drugs in accessing harm reduction and treatment services. Addressing stigma is considered a crucial step in mitigating BC's overdose crisis, by encouraging people who use drugs to feel more comfortable to access and utilize services without fear of judgment. This study examined the impacts of the decriminalization policy on stigma among people who use drugs within the first year of implementation.

Methods

From October 2023 to February 2024, 100 semi-structured telephone interviews and brief socio-demographic surveys with people who use drugs from across BC were conducted to explore their experiences of stigmatization post-decriminalization. A qualitative thematic analysis was used to synthesize the data.

Results

Findings revealed that societal, structural and self-stigma remain pervasive among people who use drugs post-decriminalization. While most participants reported little change in their experiences of stigma since the policy's implementation, some reported an increase, while others observed a decrease across all forms of stigma. Increased stigma was attributed to perceived heightened visibility of public drug use, which amplified societal stigma. Conversely, decreased stigma was linked to shifting public perceptions of drug use as a public health issue and more humanized interactions with the police. Despite mixed experiences, participants remained optimistic that the policy could contribute to long-term stigma reduction and offered recommendations to support this goal.

Conclusion

While decriminalization has the potential to reduce stigma and increase comfort in accessing critical harm reduction and substance use treatment services among people who use drugs, achieving these outcomes requires additional efforts. Public awareness campaigns, targeted anti-stigma education, and broader systemic changes were suggested by participants as essential to address stigmatization in BC. Strengthening these areas could enhance access to and utilization of services, ultimately supporting the broader goals of decriminalization.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.80
自引率
11.40%
发文量
307
审稿时长
62 days
期刊介绍: The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信